0B68 Ciric, Bogoljub - Thomas Jefferson University - Thomas Jefferson University
Bogoljub Ciric, PhD

Bogoljub Ciric, PhD

Contact Dr.  Ciric

901 Walnut Street
Suite 400
Philadelphia, PA 19107

(215) 955-9425

Most Recent Peer-reviewed Publications

  1. 1,25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation
  2. Astrocyte-derived lactosylceramide implicated in multiple sclerosis
  3. Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells
  4. Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells
  5. Erratum: CNS-specific Therapy for Ongoing EAE by Silencing IL-17 Pathway in Astrocytes(Molecular Therapy)
  6. Committed Tc17 cells are phenotypically and functionally resistant to the effects of IL-27
  7. Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis
  8. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination
  9. Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity
  10. Immune tolerance induced by intravenous transfer of immature dendritic cells via up-regulating numbers of suppressive IL-10+ IFN-γ+-producing CD4+ T cells
  11. Accelerated and enhanced effect of CCR5-transduced bone marrow neural stem cells on autoimmune encephalomyelitis
  12. CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes
  13. IL-10 deficiency blocks the ability of LPS to regulate expression of tolerance-related molecules on dendritic cells
  14. Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor
  15. Bowman-Birk inhibitor attenuates experimental autoimmune encephalomyelitis by delaying infiltration of inflammatory cells into the CNS
  16. Generation of immunogenic and tolerogenic clinical-grade dendritic cells
  17. The encephalitogenicity of TH 17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF
  18. Retraction: Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity (Cancer Research (2004) 1)
  19. Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population
  20. Evaluation of bone marrow- and brain-derived neural stem cells in therapy of central nervous system autoimmunity
0